The high court has until the end of the week to rule on whether the Food and Drug Administration should uphold its approval of mifepristone, a drug commonly used for abortions.

Reset digs into when justices are expected to drop that decision and how it could impact abortion access across the country.

GUEST: Steven Schwinn, professor at University of Illinois Chicago Law School